859 related articles for article (PubMed ID: 15792552)
1. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Joosten U; Joist A; Gosheger G; Liljenqvist U; Brandt B; von Eiff C
Biomaterials; 2005 Sep; 26(25):5251-8. PubMed ID: 15792552
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo.
Joosten U; Joist A; Frebel T; Brandt B; Diederichs S; von Eiff C
Biomaterials; 2004 Aug; 25(18):4287-95. PubMed ID: 15046919
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Yin LY; Calhoun JH; Thomas TS; Wirtz ED
J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental osteomyelitis by methicillin resistant Staphylococcus aureus with bone cement system releasing grepafloxacin.
Efstathopoulos N; Giamarellos-Bourboulis E; Kanellakopoulou K; Lazarettos I; Giannoudis P; Frangia K; Magnissalis E; Papadaki M; Nikolaou VS
Injury; 2008 Dec; 39(12):1384-90. PubMed ID: 18656187
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
[TBL] [Abstract][Full Text] [Related]
7. [Vancomycin-loaded bioactive borate glass for treatment of chronic osteomyelitis in rabbits].
Xie Z; Liu X; Jia W; Zhang C; Huang W
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jul; 25(7):830-6. PubMed ID: 21818950
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
[TBL] [Abstract][Full Text] [Related]
9. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
10. PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
Zelken J; Wanich T; Gardner M; Griffith M; Bostrom M
Clin Orthop Relat Res; 2007 Sep; 462():190-4. PubMed ID: 17514008
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits.
Jiang JL; Li YF; Fang TL; Zhou J; Li XL; Wang YC; Dong J
Inflamm Res; 2012 Mar; 61(3):207-15. PubMed ID: 22159524
[TBL] [Abstract][Full Text] [Related]
12. Novel model for studying hematogenous infection in an experimental setting of implant-related infection by a community-acquired methicillin-resistant S. aureus strain.
Poultsides LA; Papatheodorou LK; Karachalios TS; Khaldi L; Maniatis A; Petinaki E; Malizos KN
J Orthop Res; 2008 Oct; 26(10):1355-62. PubMed ID: 18425805
[TBL] [Abstract][Full Text] [Related]
13. Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit.
Giavaresi G; Borsari V; Fini M; Giardino R; Sambri V; Gaibani P; Soffiatti R
J Orthop Res; 2008 Jun; 26(6):785-92. PubMed ID: 18186130
[TBL] [Abstract][Full Text] [Related]
14. [Injectable borate glass/chitosan composite as drug carrier for treatment of chronic osteomyelitis].
Zhao C; Wang X; Zhang C; Cui X; Jia W; Huang W
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jun; 26(6):641-6. PubMed ID: 22792754
[TBL] [Abstract][Full Text] [Related]
15. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin.
Xie Z; Liu X; Jia W; Zhang C; Huang W; Wang J
J Control Release; 2009 Oct; 139(2):118-26. PubMed ID: 19545593
[TBL] [Abstract][Full Text] [Related]
16. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
Kanellakopoulou K; Galanopoulos I; Soranoglou V; Tsaganos T; Tziortzioti V; Maris I; Papalois A; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2009 Apr; 33(4):354-9. PubMed ID: 19097865
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental osteomyelitis by liposomal antibiotics.
Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model.
Li GY; Yin JM; Ding H; Jia WT; Zhang CQ
J Orthop Res; 2013 Jun; 31(6):949-56. PubMed ID: 23280538
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus osteomyelitis.
Sheftel TG; Mader JT; Pennick JJ; Cierny G
Clin Orthop Relat Res; 1985 Sep; (198):231-9. PubMed ID: 4028555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
